Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Nasopharyngeal Carcinoma 16Squamous Cell Carcinoma of Head and Neck 11Esophageal Squamous Cell Carcinoma 11Esophageal Neoplasms 9Head and Neck Neoplasms 8Uterine Cervical Neoplasms 7Pancreatic Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Pancreatic cancer, adult 2Neoplasms 2Nasopharyngeal Neoplasms 2Lung Neoplasms 2Colorectal Neoplasms 2Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Anal Canal 1Solid Tumors 1Solid Tumor 1Resectable Pancreatic Cancer 1Recurrence 1Penile Neoplasms 1Pathologic Complete Response 1Pancreatic Cancer Resectable 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Diseases 1NSCLC 1Meningeal Carcinomatosis 1Locally Advanced Rectal Cancer 1

Interventions

pembrolizumab 5Paclitaxel 4Ifosfamide 4Cisplatin 4Nivolumab 3avelumab 2aldesleukin 2Radiotherapy 2Magnetic Resonance Spectroscopy 2Adoptive Transfer 2vinflunine 1toripalimab 1rocakinogene sifuplasmid 1niraparib 1nimotuzumab 1lenvatinib 1enfortumab vedotin 1durvalumab 1dostarlimab 1dacomitinib 1cemiplimab 1cabazitaxel 1Vorinostat 1VGX-3100 1Ultrasonography 1Surveys and Questionnaires 1Sildenafil Citrate 1Sentinel Lymph Node Biopsy 1Psychiatric Rehabilitation 1Psychiatric Nursing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Penile Neoplasms × nimotuzumab × Clear all
NCT04475016 2022-06-09

TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer

Sun Yat-sen University

Phase 2 Completed
29 enrolled
Genitourinary

Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡